.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Daiichi Sankyo
Novartis
UBS
Merck
Queensland Health
Teva
Farmers Insurance
Johnson and Johnson

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,254,114

« Back to Dashboard

Summary for Patent: 4,254,114

Title: Control of pyrophosphate microorganisms with organophosphonates
Abstract:A method of selectively controlling pyrophosphate-utilizing microorganisms comprises contacting said microorganisms with an organism controlling amount of certain organophosphonate compounds. Accordingly, a method of treating amoebiasis in a human or lower animal comprises administering to a human or lower animal in need of such treatment a safe and effective amount of such organophosphonate compound. Similarly, a method of selectively controlling Propionibacteria species in the manufacture of cheese comprises incorporating an organism controlling amount of an organophosphonate compound in the raw materials for said cheese.
Inventor(s): Triebwasser; Keith C. (Cincinnati, OH)
Assignee: The Proctor & Gamble Company (Cincinnati, OH)
Application Number:06/000,320
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

International Patent Family for Patent: 4,254,114

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium880963► Subscribe
JapanH0128006► Subscribe
JapanS55120515► Subscribe
Philippines14930► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Merck
Johnson and Johnson
Covington
Daiichi Sankyo
Cerilliant
Argus Health
Cantor Fitzgerald
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot